Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 115

1.

HTLV-1 Tax-associated hTid-1, a human DnaJ protein, is a repressor of Ikappa B kinase beta subunit.

Cheng H, Cenciarelli C, Tao M, Parks WP, Cheng-Mayer C.

J Biol Chem. 2002 Jun 7;277(23):20605-10. Epub 2002 Apr 1.

2.

Human T cell leukemia virus type 1 Tax associates with a molecular chaperone complex containing hTid-1 and Hsp70.

Cheng H, Cenciarelli C, Shao Z, Vidal M, Parks WP, Pagano M, Cheng-Mayer C.

Curr Biol. 2001 Nov 13;11(22):1771-5.

5.

Human T-lymphocyte transformation with human T-cell lymphotropic virus type 2.

Tarsis SL, Yu MT, Parks ES, Persaud D, Muñoz JL, Parks WP.

J Virol. 1998 Jan;72(1):841-6.

7.

Point/counterpoint: I. HIV-1 screening of pregnant women.

Parks WP.

Obstet Gynecol Surv. 1995 Jan;50(1):1-2. No abstract available.

PMID:
7891964
8.

HIV-1 reverse transcriptase. A diversity generator and quasispecies regulator.

Muñoz JL, Parks WP, Wolinsky SM, Korber BT, Hutto C.

Ann N Y Acad Sci. 1993 Oct 29;693:65-70. Review. No abstract available.

PMID:
7505538
10.

Selective transmission of human immunodeficiency virus type-1 variants from mothers to infants.

Wolinsky SM, Wike CM, Korber BT, Hutto C, Parks WP, Rosenblum LL, Kunstman KJ, Furtado MR, Muñoz JL.

Science. 1992 Feb 28;255(5048):1134-7.

PMID:
1546316
11.
12.

A hospital-based prospective study of perinatal infection with human immunodeficiency virus type 1.

Hutto C, Parks WP, Lai SH, Mastrucci MT, Mitchell C, Munoz J, Trapido E, Master IM, Scott GB.

J Pediatr. 1991 Mar;118(3):347-53.

PMID:
1671878
13.

Human T-cell lymphotropic virus infection among blood donors in south Florida. The Transfusion Safety Study Group.

Parks WP, Lenes BA, Tomasulo PA, Schiff ER, Parks ES, Shaw GM, Lee H, Yan HQ, Lai S, Hollingsworth CG, et al.

J Acquir Immune Defic Syndr. 1991;4(1):89-96.

PMID:
1670589
14.

Congenital toxoplasmosis occurring in infants perinatally infected with human immunodeficiency virus 1.

Mitchell CD, Erlich SS, Mastrucci MT, Hutto SC, Parks WP, Scott GB.

Pediatr Infect Dis J. 1990 Jul;9(7):512-8. No abstract available.

PMID:
2371084
15.

Safety and tolerance of intermittent intravenous and oral zidovudine therapy in human immunodeficiency virus-infected pediatric patients. Pediatric Zidovudine Phase I Study Group.

McKinney RE Jr, Pizzo PA, Scott GB, Parks WP, Maha MA, Lehrman SN, Riggs M, Eddy J, Lane BA, Eppes SC, et al.

J Pediatr. 1990 Apr;116(4):640-7.

PMID:
2181102
16.

A multicenter clinical trial of oral ribavirin in HIV-infected people with lymphadenopathy: virologic observations. Ribavirin-LAS Collaborative Group.

Roberts RB, Hollinger FB, Parks WP, Rasheed S, Laurence J, Heseltine PN, Makuch RW, Lubina JA, Johnson KM.

AIDS. 1990 Jan;4(1):67-72.

PMID:
1690551
17.

Survival in children with perinatally acquired human immunodeficiency virus type 1 infection.

Scott GB, Hutto C, Makuch RW, Mastrucci MT, O'Connor T, Mitchell CD, Trapido EJ, Parks WP.

N Engl J Med. 1989 Dec 28;321(26):1791-6.

PMID:
2594038
18.

Epidemiologic background of blood donors with antibody to human T-cell lymphotropic virus. Transfusion Safety Study Group.

Operskalski EA, Schiff ER, Kleinman SH, Busch M, Taylor PE, Parks WP, Lee H, Tomasulo PA, Donegan E, Stuart M, et al.

Transfusion. 1989 Oct;29(8):746-8.

PMID:
2572078
19.

Extensive variation of human immunodeficiency virus type-1 in vivo.

Saag MS, Hahn BH, Gibbons J, Li Y, Parks ES, Parks WP, Shaw GM.

Nature. 1988 Aug 4;334(6181):440-4.

PMID:
3405290
20.

Statistical methods for the analysis of HIV-1 core polypeptide antigen data in clinical studies.

Makuch RW, Parks WP.

AIDS Res Hum Retroviruses. 1988 Aug;4(4):305-16.

PMID:
3061416
21.

HIV-1 inhibition by azidothymidine in a concurrently randomized placebo-controlled trail.

Parks WP, Parks ES, Fischl MA, Leuther MD, Allain JP, Nusinoff-Lehrman S, Barry DW, Makuch RW.

J Acquir Immune Defic Syndr. 1988;1(2):125-30.

PMID:
3145972
22.

Simultaneous infections with human T cell leukemia virus type I and the human immunodeficiency virus.

Kanner SB, Parks ES, Scott GB, Parks WP.

J Infect Dis. 1987 Apr;155(4):617-25.

PMID:
2880917
23.

Human retroviral env and gag polypeptides: serologic assays to measure infection.

Kanner SB, Cheng-Mayer C, Geffin RB, Parks WP, Beltz GA, Arthur LO, Samuel KP, Papas TS.

J Immunol. 1986 Jul 15;137(2):674-8.

PMID:
3014000
24.

Genetic variation in HTLV-III/LAV over time in patients with AIDS or at risk for AIDS.

Hahn BH, Shaw GM, Taylor ME, Redfield RR, Markham PD, Salahuddin SZ, Wong-Staal F, Gallo RC, Parks ES, Parks WP.

Science. 1986 Jun 20;232(4757):1548-53.

PMID:
3012778
25.

Identification and characterization of conserved and variable regions in the envelope gene of HTLV-III/LAV, the retrovirus of AIDS.

Starcich BR, Hahn BH, Shaw GM, McNeely PD, Modrow S, Wolf H, Parks ES, Parks WP, Josephs SF, Gallo RC, et al.

Cell. 1986 Jun 6;45(5):637-48.

PMID:
2423250
26.

On the pathogenesis of immune incompetence in the acquired immune deficiency syndrome.

Streilein JW, Parks WP.

Bioessays. 1986 Jun;4(6):286-91. No abstract available.

PMID:
3491610
27.
28.

Pediatric AIDS: a disease spectrum causally associated with HTLV-III infection.

Parks WP, Scott GB.

Cancer Res. 1985 Sep;45(9 Suppl):4659s-4661s. No abstract available.

29.

Mothers of infants with the acquired immunodeficiency syndrome. Evidence for both symptomatic and asymptomatic carriers.

Scott GB, Fischl MA, Klimas N, Fletcher MA, Dickinson GM, Levine RS, Parks WP.

JAMA. 1985 Jan 18;253(3):363-6.

PMID:
3965789
30.

Antigenic determinants in a virus-induced mouse mammary tumor recognized by cell-mediated immune assays.

Lopez PF, Parks WP, Lopez DM.

J Natl Cancer Inst. 1984 Mar;72(3):725-32.

PMID:
6199544
31.

Acquired immunodeficiency syndrome in infants.

Scott GB, Buck BE, Leterman JG, Bloom FL, Parks WP.

N Engl J Med. 1984 Jan 12;310(2):76-81.

PMID:
6606781
33.

Kaposi sarcoma in two infants with acquired immune deficiency syndrome.

Buck BE, Scott GB, Valdes-Dapena M, Parks WP.

J Pediatr. 1983 Dec;103(6):911-3. No abstract available.

PMID:
6644425
34.

Lymphoproliferative responses to mouse mammary tumor virus in lymphocyte subsets of breast cancer patients.

Lopez DM, Parks WP, Silverman MA, Distasio JA.

J Natl Cancer Inst. 1981 Aug;67(2):353-8.

PMID:
6267344
35.

Quantitation in the evaluation of cell substrates for viral vaccine production.

Parks WP, Hubbell ES.

Adv Exp Med Biol. 1979;118:23-33. No abstract available.

PMID:
495268
36.

Leukocyte migration inhibition and lymphocyte blastogenesis responses in breast carcinoma patients to mouse mammary tumor virus and to virion gp52 antigen and Rauscher murine leukemia virus-Kirsten sarcoma virus gp69/71 antigen.

McCoy JL, Dean JH, Cannon GB, Jerome LJ, Alford TC, Parks WP, Gilden RV, Oroszlan ST, Herberman RB.

J Natl Cancer Inst. 1978 Jun;60(6):1259-67. No abstract available.

PMID:
206704
37.

Eukaryotic gene regulation studies with mouse mammary tumor virus in tissue culture cells.

Parks WP, Young HA, Scolnick EM.

Natl Cancer Inst Monogr. 1978 May;(48):215-8.

PMID:
219353
38.

Characterization of a feline leukemia viral cell membrane antigen reactive with feline sera.

Ruscetti SK, Parks WP.

J Immunol. 1977 Dec;119(6):2194-202. No abstract available.

PMID:
72119
39.
40.

In vitro translation of Harvey murine sarcoma virus RNA.

Parks WP, Scolnick EM.

J Virol. 1977 Jun;22(3):711-9.

43.

Isolation of a fibroblast nonproducer cell line containing the Friend strain of the spleen focus-forming virus.

Troxler DH, Parks WP, Vass WC, Scolnick EM.

Virology. 1977 Feb;76(2):602-15. No abstract available.

PMID:
190768
44.
45.

Purification and characterisation of viral RNA of a sarcoma virus isolated from a woolly monkey.

Scolnick EM, Williams D, Parks WP.

Nature. 1976 Dec 23-30;264(5588):809-11. No abstract available.

PMID:
189198
46.
47.

Expression of feline type-C virus in normal and tumor tissues of the domestic cat.

Levin R, Ruscetti SK, Parks WP, Scolnick EM.

Int J Cancer. 1976 Nov 15;18(5):661-71.

PMID:
186414
48.

Natural immunity in cats to feline leukemia viral antigens.

Ruscetti SK, Parks WP.

J Immunol. 1976 Nov;117(5 Pt.2):2029-35.

PMID:
186536
49.
50.

High frequency variation in mammary tumor virus expression in cell culture.

Parks WP, Hubbell ES, Goldberg RJ, O'Neill FJ, Scolnick EM.

Cell. 1976 May;8(1):87-93.

PMID:
182380

Supplemental Content

Loading ...
Support Center